CellViva™ is an early stage biotech company developing solutions for better healing.
CellViva™ has developed a proprietary compound that targets a variety of dermatological conditions including keloid and hypertrophic scar growth, pterygium, pyogenic granuloma, and other difficult to treat conditions. Cellviva plans to augment or replace existing therapies to achieve improved long term results with its patented and proprietary technology.
Cellviva has assembled a team of leading scientists, clinical investigators, and strategic partners in its market sector.Please comeback for more information to learn about CellViva’s novel technology and solutions to improve healing of skin and other tissue post surgery or trauma.
